Tyra Biosciences, Inc. · NASDAQ:TYRA
Vestal Point Capital, LP reported a 5.40% stake in Tyra Biosciences, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Vestal Point Capital, LP reported a 5.40% stake in Tyra Biosciences, Inc., 2,879,829 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 2,879,829
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 5.40% | 2,879,829 |
| Ryan Wilder | 5.40% | 2,879,829 |
Source
Related
- Tyra Biosciences, Inc.
- Vestal Point Capital, LP
- Tyra Biosciences, Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · Nov 14, 2025
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026